Home

arrow iconNewsarrow iconarrow icon

Can AI Pick IVF Embryos Better Than Humans?

Can AI Pick IVF Embryos Better Than Humans?

A groundbreaking Nature Medicine study compares AI deep learning against expert embryologists in selecting embryos. While pregnancy rates remain comparable, the study uncovers a massive advantage in efficiency that could revolutionize IVF labs worldwide. Discover how AI-driven embryo selection accuracy is reshaping the future of fertility treatment.

By FertilityIn

10 Dec 2025

4 min read

AI Birth, AI Pick IVF Embryos

AI Birth, AI Pick IVF Embryos

The Race for Precision in IVF

In the high-stakes world of In Vitro Fertilization (IVF), the decision of which embryo to transfer can be the difference between a successful pregnancy and heartbreak. For decades, this immense responsibility has rested on the experienced shoulders of clinical embryologists, who meticulously analyze embryos under a microscope. But a new contender has entered the lab: Artificial Intelligence.


A major new study published in Nature Medicine has finally provided a rigorous answer to the question on everyone's mind: Can AI-driven embryo selection accuracy outperform human expertise? The results are in, and while they might surprise you, they paint a promising future for aspiring parents.


The Study: AI vs. Human Expertise

The research, led by Dr. Peter Illingworth and a global team of scientists, was a randomized, double-blind, non-inferiority trial conducted across 14 IVF clinics in Australia and Europe. It represents one of the most comprehensive real-world tests of deep learning in reproductive medicine to date.​

The study compared two methods of selection:

  1. The Human Approach: Experienced embryologists using standard morphological assessment (Gardner grading) to choose the best blastocyst.
  2. The AI Approach: A deep learning algorithm known as iDAScore (developed by Vitrolife), which analyzed time-lapse images to generate a viability score.

The trial involved women under 42 years of age with at least two viable blastocysts. The goal was to see if the AI could match or beat the clinical pregnancy rates achieved by humans.​


The Verdict: Comparable Accuracy, Unmatched Speed

The findings revealed that AI is not yet the "magic bullet" that drastically increases pregnancy rates overnight, but it is a highly competent assistant.

  • Pregnancy Rates: The clinical pregnancy rate for the AI-selected group was 46.5%, compared to 48.2% for the embryologist-selected group.
  • Statistical Significance: The difference was statistically insignificant, meaning the AI performed effectively on par with human experts in a real-world clinical setting.​

While the AI did not demonstrate "superiority" in raw pregnancy numbers, it matched the high standards of human care. This is a critical validation for AI-driven embryo selection accuracy, proving it is safe and reliable.


The Real Revolution: 10x Faster Workflow

If the success rates are similar, why switch to AI? The answer lies in efficiency. The study found that the AI system was significantly faster than its human counterparts.

  • Speed: The AI required far less time to assess embryos, completing the selection process 10 times faster than embryologists.​
  • Consistency: Unlike humans, who may suffer from fatigue or subjective bias after hours of analysis, the AI provides an objective, standardized score every single time.​

This efficiency could be a game-changer for busy clinics. By automating the time-consuming selection process, embryologists can free up valuable time to focus on complex procedures like micromanipulation and patient interaction, potentially reducing burnout and improving overall lab workflow.


What This Means for Patients

For patients undergoing IVF, these findings offer reassurance and hope.

  • Standardization: AI offers a "second opinion" that is objective and data-driven, reducing the variability between different clinics or individual embryologists.
  • Access: As AI tools become more prevalent, they could help democratize high-quality care, ensuring patients in smaller clinics receive the same level of embryo assessment as those in major research centers.
  • Future Potential: This is just version 1.0. As deep learning models ingest more data, their ability to detect subtle features invisible to the human eye, such as metabolic activity or genetic likelihood—will likely improve, potentially raising success rates in the future.


Conclusion

So, can AI pick IVF embryos better than humans? In terms of raw pregnancy outcomes today, the answer is "not yet." However, in terms of speed, consistency, and workflow efficiency, AI is already winning. As AI-driven embryo selection accuracy continues to evolve, the partnership between human expertise and machine learning will likely become the new gold standard in fertility care, bringing us one step closer to helping more families grow.

15 views

Share

FertilityIn

Send Enquiry for this Story

Previous News

AURA, World's First AI-Powered Automated IVF Lab, Delivers 18 Healthy AI-Assisted Babies

Next News

Healthy Twin Births Reported After Aneuploid Embryo Transfer in IVF

Related Articles

Luna and Kindbody Partner to Advance Data-Driven Intelligence in Fertility Care

Luna and Kindbody Partner to Advance Data-Driven Intelligence in Fertility Care

Luna and Kindbody are redefining Intelligence in Fertility Care through a strategic partnership that integrates wearable biomarker tracking into clinical pathways. By capturing real-time physiological data, the collaboration enables personalised insights, enhances decision-making, and creates a more connected, data-driven fertility journey for patients and care providers alike.

ART

1 min read

Sapyen and Avenues Launch At-Home Fertility Diagnostics in UK

Sapyen and Avenues Launch At-Home Fertility Diagnostics in UK

Sapyen and Avenues launch at-home fertility diagnostics, introducing a couple-first testing model in the UK. By integrating semen analysis and AMH testing into early care, this approach reduces clinic visits, accelerates diagnosis, and ensures balanced fertility evaluation, transforming how patients begin their reproductive health journey.

ART

1 min read

Nexpring Health Invests in Technology for PCOS-Related Infertility

Nexpring Health Invests in Technology for PCOS-Related Infertility

Nexpring Health has invested in May Health to accelerate the development of the Anavi™ System, a novel device designed to treat PCOS-Related Infertility. The technology aims to restore ovulation through a single office-based procedure, expanding treatment options for millions of women affected by polycystic ovary syndrome.

ART

1 min read

INVO Fertility to Introduce Time-Lapse Incubation Technology to Enhance IVF Success Rates and Patient Outcomes

INVO Fertility to Introduce Time-Lapse Incubation Technology to Enhance IVF Success Rates and Patient Outcomes

INVO Fertility would be introducing time-lapse incubation technology at its Wisconsin clinic, hence offering high-quality lab care, creative patient solutions, and advanced embryo monitoring for improved fertility results.

ART

1 min read

Industry Leaders to Transform Fertility Care in the U.S. Through Groundbreaking Partnership Making Treatment More Accessible

Industry Leaders to Transform Fertility Care in the U.S. Through Groundbreaking Partnership Making Treatment More Accessible

Costco, Sesame, and IVI RMA North America have announced strategic partnership to alter fertility care in the U.S. by removing biggest obstacles to care including high costs and limited access.

ART

1 min read

Carea Launches the Trying to Conceive - IVF/IUI Mode to Empower Women with Seamless and Reliable Digital Support

Carea Launches the Trying to Conceive - IVF/IUI Mode to Empower Women with Seamless and Reliable Digital Support

Carea has launched its Trying to Conceive - IVF/IUI mode to help women undergoing intricate fertility treatment with risks of inconsistent clinic continuity through continuous tracking and expert guidance.

ART

1 min read

Minnesota Bill for Infertility Treatments Expands Insurance Coverage by 2027

Minnesota Bill for Infertility Treatments Expands Insurance Coverage by 2027

The Minnesota bill for infertility treatments mandates comprehensive insurance coverage for diagnosis, IVF, and fertility preservation across public and private health plans. Set for implementation in 2027, the legislation expands access, modernises infertility definitions, and ensures cost-sharing protections to make reproductive healthcare more equitable.

ART

1 min read

Landing Page Image

Subscribe to our Newsletter

Stay updated with the latest news, expert insights, and exclusive offers delivered straight to your inbox. Join our community today!

Email Address